- Home
- ZTG vs QNCX Comparison
ZTG vs QNCX Comparison
Compare ZTG & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$3.82
HOLD
Current Price
$24.11
Company Overview
Basic Information| Metric | ZTG | QNCX |
|---|---|---|
| Founded | N/A | 2012 |
| Country | Macau | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.4M | 17.5M |
| IPO Year | 2025 | 2019 |
Fundamental Metrics
Financial Performance| Metric | ZTG | QNCX |
|---|---|---|
| Price | $3.82 | $24.11 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 157.8K | 32.5K |
| Earning Date | N/A | 04-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.88 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $8.00 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.46 | $0.08 |
| 52 Week High | $3.50 | $23.66 |
Technical Indicators
Market Signals| Indicator | ZTG | QNCX |
|---|---|---|
| Relative Strength Index (RSI) | 69.34 | 81.52 |
| Support Level | $2.40 | $0.68 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.37 | 1.77 |
| MACD | 0.01 | -0.11 |
| Stochastic Oscillator | 89.93 | 84.19 |
Price Performance
Historical Comparison ZTG
QNCX
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. Its proprietary AIDE technology is an inventive drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells. Its Phase 3 asset, eDSP, leverages the AIDE technology to encapsulate DSP into a patient's own red blood cells, and is targeted to treat a rare pediatric neurodegenerative disease, A-T.